Transfusion

“Least incompatible” units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals
pp. 1503-1507(5)
Author: Petz L.D.

Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII
pp. 1508-1513(6)
Authors: Freedman J.; Rand M.L.; Russell O.; Davis C.; Cheatley P.L.; Blanchette V.; Bernadette Garvey M.

Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor
pp. 1514-1521(8)
Authors: Pomper G.J.; Rick M.E.; Epstein J.S.; Read E.J.; Leitman S.F.

Residual cell content in plasma produced by three centrifugal apheresis procedures
pp. 1522-1526(5)
Authors: Burnouf T.; Kappelsberger C.; Frank K.; Burkhardt T.

Effects of rejuvenation and frozen storage on 42-day-old AS-3 RBCs
pp. 1527-1532(6)
Authors: Lockwood W.B.; Hudgens R.W.; Szymanski I.O.; Teno R.A.; Gray A.D.

Laser-assisted optical rotational cell analyzer measurements reveal early changes in human RBC deformability induced by photodynamic treatment
pp. 1533-1537(5)
Authors: Hardeman M.R.; Besselink G.A.J.; Ebbing I.; de Korte D.; Ince C.; Verhoeven A.J.

Hemochromatosis subjects as allogeneic blood donors: a prospective study
pp. 1538-1544(7)
Authors: Leitman S.F.; Browning J.N.; Yau Y.Y.; Mason G.; Klein H.G.; Conry-Cantilena C.; Bolan C.D.

Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial
pp. 1545-1552(8)
Authors: Enright H.; Davis K.; Gernsheimer T.; McCullough J.J.; Woodson R.; Slichter S.J.

TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia
pp. 1553-1557(5)
Authors: Urahama N.; Tanosaki R.; Masahiro K.; Iijima K.; Chizuka A.; Kim S-W.; Hori A.; Kojima R.; Imataki O.; Makimito A.; Mineishi S.; Takaue Y.

HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery
pp. 1558-1562(5)
Authors: Sentjens R.; Basaras M.; Simmonds P.; Vrielink H.; Reesink H.

Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study
pp. 1563-1566(4)
Authors: Seltsam A.; Wagner F.F.; Salama A.; Flegel W.A.

The matrix protein pp65_341-350: a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele
pp. 1567-1574(8)
Authors: Provenzano M.; Lim J-B.; Mocellin S.; Monsurro V.; Bettinotti M.; Marincola F.M.; Stroncek D.F.

Increased transmigration of G–CSF-mobilized peripheral blood CD34+ cells after overnight storage at 37°C
pp. 1575-1586(12)
Authors: Greco N.J.; Lee W.R.; Moroff G.

Bacterial contamination of ex vivo processed PBPC products under clean room conditions
pp. 1587-1595(9)
Authors: Ritter M.; Schwedler J.; Beyer J.; Movassaghi K.; Mutters R.; Neubauer A.; Schwella N.

Behavioral and infectious disease risks in young blood donors: implications for recruitment
pp. 1596-1603(8)
Authors: Damesyn M.A.; Glynn S.A.; Schreiber G.B.; Ownby H.E.; Bethel J.; Fridey J.; McMullen Q.; Garratty G.; Busch M.P.

RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients
pp. 1604-1610(7)
Authors: Ameen R.; Al-Shemmari S.; Al-Humood S.; Chowdhury R.I.; Al-Eyaadi O.; Al-Bashir A.

Weakening or loss of antibody reactivity after prewarm technique
pp. 1611-1614(4)
Authors: Leger R.M.; Garratty G.

Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate
pp. 1615-1621(7)
Authors: Buchta C.; Macher M.; Bieglmayer C.; Höcker P.; Dettke M.

Blood use in war and disaster: lessons from the past century
pp. 1622-1633(12)
Authors: Hess J.R.; Thomas M.J.G.

On bowling alone and donor recruitment: lessons to be learned
pp. 1634-1638(5)
Authors: Kolins J.; Herron R.

Monitoring the nation's blood supply
pp. 1639-1639(1)
Authors: Chapman J.; Hick R.

Reply
pp. 1639-1640(2)
Author: Wallace E.L.

A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia
pp. 1640-1641(2)
Authors: Leger R.M.; Arndt P.A.; Garratty G.

HTLV-I and -II in southwestern Greece
pp. 1641-1642(2)
Authors: Tseliou P.M.; Spanakis N.; Spiliotakara A.; Politis C.; Legakis N.J.; Tsakris A.

Management of pregnancy complicated by anti-Di^b
pp. 1642-1643(2)
Authors: Win N.; Madan B.; Harrison C.; Needs M.

Book Reviews
pp. 1644-1644(1)

Pediatric Hematopathology
pp. 1644-1644(1)
Author: Xu Y.

Evidence-Based Practice of Transfusion Medicine
pp. 1644-1645(2)
Author: Kanter M.H.

Handbook of Transfusion Medicine
pp. 1645-1646(2)
Author: Roseff S.D.

Calendar
pp. 1647-1648(2)